AIM Company Profile and Key Details

Q: Who are the executives of AIM?

Dr. Carol A. SmithChief Manufacturing Officer & Deputy Chief Scientific OfficerDr. Christopher McAleer Ph.D.Scientific OfficerDr. David R. Strayer M.D.Chief Scientific Officer & Medical DirectorAnn Marie E. CoverlyDirector of Admin. & HR and Deputy Investor Relations CoordinatorJodie PelzControllerDr. Ralph Christopher Cavalli Ph.D.Vice President of QC & ManufacturingMr. Thomas K. Equels Esq., J.D., M.S.Executive Vice Chairman, Chief Executive Officer & PresMr. Peter W. Rodino III, Esq., J.D.Chief Operating Officer, Executive Director of Gov.al Relations, Gen. Counsel & Sec.

AMEX : AIM

AIM ImmunoTech

$0.25

-0.00380001-1.53%

Open: 9:53 AM

63.57

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

AIM ImmunoTech Inc. (AIM) stock declined over -1.53%, trading at $0.25 on AMEX, down from the previous close of $0.25. The stock opened at $0.25, fluctuating between $0.25 and $0.25 in the recent session.

Stock Snapshot

0.249

Prev. Close

834.55K

Market Cap

0.2452

Day Low

-0.04

P/E Ratio

-6.37843

EPS (TTM)

-0.45

Cash Flow per Share

0.25

Open

3.4M

Number of Shares

0.2481

Day High

95.49%

Free Float in %

0.21

Book Value

131.68K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 21, 2026	0.25	0.26	0.24	0.25	624.88K
Jul 20, 2026	0.26	0.26	0.24	0.25	579.75K
Jul 17, 2026	0.27	0.27	0.25	0.26	479.72K
Jul 16, 2026	0.27	0.28	0.26	0.27	628.5K
Jul 15, 2026	0.27	0.28	0.26	0.26	409.05K
Jul 14, 2026	0.26	0.27	0.25	0.27	582.2K
Jul 13, 2026	0.28	0.29	0.25	0.27	910.1K
Jul 10, 2026	0.29	0.29	0.28	0.28	273.37K
Jul 09, 2026	0.30	0.30	0.28	0.29	406K
Jul 08, 2026	0.30	0.30	0.27	0.29	661.44K
Jul 07, 2026	0.30	0.31	0.29	0.31	560.41K
Jul 06, 2026	0.29	0.30	0.29	0.30	621.94K
Jul 02, 2026	0.30	0.31	0.28	0.28	970.48K
Jul 01, 2026	0.29	0.30	0.28	0.30	841.27K
Jun 30, 2026	0.29	0.29	0.26	0.28	1.08M
Jun 29, 2026	0.31	0.31	0.28	0.30	2.09M
Jun 26, 2026	0.34	0.35	0.30	0.31	2.07M
Jun 25, 2026	0.36	0.37	0.34	0.36	1.11M
Jun 24, 2026	0.35	0.38	0.33	0.37	3.4M
Jun 23, 2026	0.37	0.37	0.35	0.36	1.19M

Contact Details

Ocala, FL 34473

United States

https://aimimmuno.com 352 448 7797

About Company

AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida, focuses on discovering and advancing treatments for a diverse array of cancers, viral infections, and immune system disorders across the United States. Its primary drug offerings include Ampligen (rintatolimod), a large macromolecular double-stranded ribonucleic acid compound developed for chronic fatigue syndrome, and Alferon N Injection (Interferon alfa), a purified, naturally derived, multi-species alpha interferon prescribed for genital warts. Furthermore, Ampligen is currently undergoing investigation for its potential application in treating pancreatic, renal cell, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company, originally incorporated in 1966, was formerly known as Hemispherx Biopharma, Inc. until its name change in August 2019.

Stock Peers

PTHS

-0.4-1.47%

Pelthos Therapeutics Inc.$26.86 AGE

-1.5-11.90%

AgeX Therapeutics, Inc.$11.10 CYBN

0.1+1.22%

Cybin Inc.$8.28 NRXS

0.15+2.19%

NeurAxis, Inc.$7.01 ARMP

0.1+1.98%

Armata Pharmaceuticals, Inc.$5.16 CANF

0.07+2.11%

Can-Fite BioPharma Ltd.$3.38 PLX

-0.05-2.07%

Protalix BioTherapeutics, Inc.$2.36 SER

-0.09-4.13%

Serina Therapeutics, Inc.$2.09 NNVC

-0.15-8.57%

NanoViricides, Inc.$1.60 OSTX

0.05+3.31%

OS Therapies Incorporated$1.56

Frequently Asked Questions

What is the current AIM ImmunoTech Inc. (AIM) stock price?

AIM ImmunoTech Inc. (AMEX: AIM) stock price is $0.25 in the last trading session. During the trading session, AIM stock reached the peak price of $0.25 while $0.25 was the lowest point it dropped to. The percentage change in AIM stock occurred in the recent session was -1.53% while the dollar amount for the price change in AIM stock was - $0.00.

AIM's industry and sector of operation?

The AMEX listed AIM is part of Biotechnology industry that operates in the broader Healthcare sector. AIM ImmunoTech Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of AIM?

Dr. Carol A. Smith
Chief Manufacturing Officer & Deputy Chief Scientific Officer
Dr. Christopher McAleer Ph.D.
Scientific Officer
Dr. David R. Strayer M.D.
Chief Scientific Officer & Medical Director
Ann Marie E. Coverly
Director of Admin. & HR and Deputy Investor Relations Coordinator
Jodie Pelz
Controller
Dr. Ralph Christopher Cavalli Ph.D.
Vice President of QC & Manufacturing
Mr. Thomas K. Equels Esq., J.D., M.S.
Executive Vice Chairman, Chief Executive Officer & Pres
Mr. Peter W. Rodino III, Esq., J.D.
Chief Operating Officer, Executive Director of Gov.al Relations, Gen. Counsel & Sec.

How AIM did perform over past 52-week?

AIM's closing price is 18.57% higher than its 52-week low of $0.21 where as its distance from 52-week high of $19.74 is -98.74%.

How many employees does AIM have?

Number of AIM employees currently stands at 19.

Link for AIM official website?

Official Website of AIM is: https://aimimmuno.com

How do I contact AIM?

AIM could be contacted at phone 352 448 7797 and can also be accessed through its website. AIM operates from 2117 SW Highway 484, Ocala, FL 34473, United States.

How many shares of AIM are traded daily?

AIM stock volume for the day was 131.68K shares. The average number of AIM shares traded daily for last 3 months was 28.29M.

What is the market cap of AIM currently?

The market value of AIM currently stands at $834.55K with its latest stock price at $0.25 and 3.4M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	19
Beta	1.2
Sales or Revenue	$202.00K
5Y Sales Change%	-0.989%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	19
Beta	1.2
Sales or Revenue	$202.00K
5Y Sales Change%	-0.989%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

AIM Company Profile and Key Details

AIM ImmunoTech

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways